Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
Michelle R Ananda-Rajah, Andrew Grigg, Maria T Downey, Ashish Bajel, Tim Spelman, Allen Cheng, Karin T Thursky, Janette Vincent, Monica A Slavin
Haematologica | FERRATA STORTI FOUNDATION | Published : 2012
Funding: National Health and Medical Research Council post-graduate medical scholarship to MA-R. This study received no external funding. Manuscript received on July 20, 2011. Revised version arrived on October 17, 2011. Manuscript accepted on October 17, 2011.